Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BR(E)2ASTOME: Liquid Biopsy and Network Medicine in Breast Cancer
NCT04996836Phase 2Unknown
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Jan 2022
- Primary completion
- Dec 2022
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoints: Evaluation of Network-oriented biomarkers in prognosis of BC at 1 year and Evaluation of Network-oriented biomarkers of Drug Response at 2 years. Status: unknown.
Beyond the preview
Go deeper on NCT04996836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04996836.